Current Drug Targets

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Editorial [Hot Topic: The Fabisch-Symposium 2009 on Targeted Tumor Therapies(Guest Editors: C. Bachran and H. Fuchs)] promotion: free to download

Volume:10   Issue:2
Pp: 88-88
Christopher Bachran and Hendrik Fuchs
DOI: 10.2174/138945009787354548

Order Reprints Order Eprints

Targeted Tumor Therapies at a Glance

Volume:10   Issue:2
Pp: 89-93
H. Fuchs and C. Bachran
DOI: 10.2174/138945009787354557

Order Reprints Order Eprints

Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma

Volume:10   Issue:2
Pp: 104-109
A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville and J. H. Woo
DOI: 10.2174/138945009787354539

Order Reprints Order Eprints

Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo

Volume:10   Issue:2
Pp: 110-117
B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop
DOI: 10.2174/138945009787354566

Order Reprints Order Eprints

Saponins as Tool for Improved Targeted Tumor Therapies

Volume:10   Issue:2
Pp: 140-151
H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland and C. Bachran
DOI: 10.2174/138945009787354584

Order Reprints Order Eprints